Hepatitis C disease severity in living versus deceased donor liver transplant recipients: An extended observation study
Norah A. Terrault, R. Todd Stravitz, Anna S.F. Lok, Greg T. Everson, Robert S. Brown, Laura M. Kulik, Kim M. Olthoff, Sammy Saab, Ovedele Adeyi, Curtis K. Argo, Jay E. Everhart, Del R. Rodrigo, the A2ALL Study Group – 31 October 2013 – Donor factors influence hepatitis C virus (HCV) disease severity in liver transplant (LT) recipients. Living donors, because they are typically young and have short cold ischemic times, may be advantageous for HCV‐infected patients.